When one institution gave radiologists a programmable 13-button mouse over a two-day period, many preferred the non-conventional device over the traditional three-button variety, according to a study published in the Journal of Digital Imaging.

Researchers from Brigham and Women's Hospital in Boston have developed “surgery in a pill” to treat type 2 diabetes by lowering blood glucose levels after a meal. The newly developed approach was outlined in a study published June 11 in Nature Materials.

Five months before the 2018 midterm elections, California Republicans see their opponents’ embrace of exploring single-payer healthcare as an opportunity.

Including MRI in the routine evaluation of endometrial cancer could help assess the aggressiveness of tumors while stratifying which patients may benefit from surgeries like lymphadenectomy, researchers reported in Clinical Radiology this June.

On Monday, June 11, CMS released guidance for states to leverage Medicaid in fighting opioid abuse and misuse—with the document making specific mention of efforts to reduce negative impact in infants and outlining potential benefits of health information technology.

A groundbreaking new treatment that involves a magnetic metal “seed” and an MRI scanner could destroy deadly brain tumors in 10 minutes, according to a June 8 article in The Telegraph.

Private equity firm KKR & Co. announced its plan to buy Envision Healthcare for $5.57 billion and debt. The all-cash transaction will value Envision at $9.9 billion, according to Bloomberg.

A team of researchers from Auburn University in Alabama believe art classes can have a meaningful impact on the brain—which may lead to a deeper understanding of cognitive conditions such as depression.

A $90,000 grant from the National Endowment for the Arts is offering Auburn University imagers an opportunity to study the effect art classes can have on brain plasticity, the university announced this week. Results could have important implications for how cognitive impairment cases are handled.

A scientist at the American Society of Clinical Oncology (ASCO)’s annual meeting discussed how cardiac imaging and biomarker measurements could improve care for cancer survivors.